Unknown

Dataset Information

0

EGFRvIII vs. Control - xenograft glioblastomas

ABSTRACT: Glioblastoma cell lines were xenografted onto mice and resulting tumors were profiled by microarray. Xenograft recipient mice were NOD/SCID/gamma (NSG) male mice 3 months old. In this set, 6 total samples were analyzed. There were three biological replicates for each of two conditions: EGFRvIII containing tumors and control. Arrays were analyzed for gene expression using GeneBase and for alternative splicing using MADS+ software.

ORGANISM(S): Homo sapiens

SUBMITTER: Anderson Erik 

PROVIDER: S-ECPF-GEOD-46028 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Transcriptomics EGFRvIII vs. Control - xenograft glioblastomas
2013-07-01 | GSE46028 | GEO
Transcriptomics EGFRvIII vs. Control - xenograft glioblastomas
2013-07-01 | E-GEOD-46028 | biostudies-arrayexpress
Unknown Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.
| S-EPMC4494902 | biostudies-other
Unknown Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.
| S-EPMC5762005 | biostudies-literature
Unknown The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
| S-EPMC2714280 | biostudies-literature
Unknown EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery.
| S-EPMC5341612 | biostudies-literature
Unknown Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.
| S-EPMC6781999 | biostudies-literature
Unknown The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas.
| S-EPMC3815450 | biostudies-other
Unknown Patient specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ
| S-ECPF-GEOD-42670 | biostudies-other
Unknown Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma.
| S-EPMC2841188 | biostudies-literature